Abbott Collaborates with Insulet to Integrate Glucose Sensing Technology with Automated Insulin Delivery System for Seamless Diabetes Care

 Abbott Collaborates with Insulet to Integrate Glucose Sensing Technology with Automated Insulin Delivery System for Seamless Diabetes Care

Abbott Collaborates with Insulet to Integrate Glucose Sensing Technology with Automated Insulin Delivery System for Seamless Diabetes Care

Shots:

  • The collaboration will combine Abbott’s CGM technology with Insulet’s Omnipod Horizon system to provide accurate, easy-to-use, integrated digital health platform to the patients living with diabetes
  • The integrated system is designed to remain in automated insulin delivery mode and is controlled via an app on a user’s smartphone to manually take a dose of fast-acting insulin/ bolus/before meals for optimal performance
  • Abbott’s FreeStyle Libre is a sensor-based CGM system that reads glucose levels via a sensor that can be worn on the back of the upper arm eliminating the need for fingerstick while the Omnipod is an insulin delivery system that consists of pod holding up to 200 units of U-100 insulin and a PDM controlling the pod

Click here ­to­ read full press release/ article | Ref: Abbott | Image: FreeStyle Libre, Omnipod

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post